Wound Treatments - India

Date: March 22, 2010
Pages: 49
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: W5BD74A3F20EN
Leaflet:

Download PDF Leaflet

Wound treatments value sales reached Rs2,085 million in 2009. This category was not dynamic in terms of new product launches and marketing campaigns, and growth was driven largely by rising purchasing power, which has resulted in consumers purchasing branded products for the treatment of wounds. “Other” wound treatments grew slightly faster than sticking plasters in 2009, albeit from a much smaller base.

Euromonitor International's Wound Treatments Products in India report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Other Wound Treatments, Sticking Plasters

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Wound Treatments in India
Euromonitor International
March 2010

LIST OF CONTENTS AND TABLES

Executive Summary
Consumer Healthcare Products Increase Penetration
H1n1 Flu Scare Positively Affects Consumer Healthcare
Top Three Players Continue To Gain Market Share
Independent Chemists Continue To Dominate
Robust Growth To Continue
Key Trends and Developments
H1n1 Flu Scare Affects Consumer Healthcare in India
Private Label Brands Make A Limited Appearance
Niche Products Increase Visibility
Players Embrace Ayurvedic Ingredients
Regulatory Environment Remains Uncertain
Territory Key Trends and Developments
East and Northeast India
North India
South India
West India
Rural Vs Urban Key Trends and Developments
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Sales of Consumer Health by Region: Value 2004-2009
  Table 6 Sales of Consumer Health by Region: % Value Growth 2004-2009
  Table 7 Sales of Consumer Health by Rural-Urban % Value Analysis 2009
  Table 8 Consumer Health Company Shares by Value 2005-2009
  Table 9 Consumer Health Brand Shares by Value 2006-2009
  Table 10 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 11 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 12 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 13 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
  Table 14 Forecast Sales of Consumer Health by Region: Value 2009-2014
  Table 15 Forecast Sales of Consumer Health by Region: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sector and Subsector Definitions
  Summary 1 Research Sources
Amrutanjan Health Care Ltd
Strategic Direction
Key Facts
  Summary 2 Amrutanjan Health Care Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 3 Amrutanjan Health Care Ltd: Competitive Position 2009
Amway India Enterprises
Strategic Direction
Key Facts
  Summary 4 Amway India Enterprises: Key Facts
Company Background
Production
Competitive Positioning
  Summary 5 Amway India Enterprises: Competitive Position 2009
Dabur India Ltd
Strategic Direction
Key Facts
  Summary 6 Dabur India Ltd: Key Facts
  Summary 7 Dabur India Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 8 Dabur India Ltd: Competitive Position 2009
Emami Ltd
Strategic Direction
Key Facts
  Summary 9 Emami Ltd: Key Facts
  Summary 10 Emami Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 11 Emami Ltd: Competitive Position 2009
Novartis India Ltd
Strategic Direction
Key Facts
  Summary 12 Novartis India Ltd: Key Facts
  Summary 13 Novartis India Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 14 Novartis India Ltd: Competitive Position 2009
Paras Pharmaceuticals Ltd
Strategic Direction
Key Facts
  Summary 15 Paras Pharmaceuticals Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 16 Paras Pharmaceuticals Ltd: Competitive Position 2009
Pfizer Ltd
Strategic Direction
Key Facts
  Summary 17 Pfizer Ltd: Key Facts
  Summary 18 Pfizer Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 19 Pfizer Ltd: Competitive Position 2009
Plethico Pharmaceuticals Ltd
Strategic Direction
Key Facts
  Summary 20 Plethico Pharmaceuticals Ltd: Key Facts
Company Background
Production
Competitive Positioning
Procter & Gamble Hygiene & Health Care Ltd
Strategic Direction
Key Facts
  Summary 21 Procter & Gamble Hygiene & Healthcare Ltd: Key Facts
  Summary 22 Procter & Gamble Hygiene & Health Care Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 23 Procter & Gamble Hygiene & Healthcare Ltd: Competitive Position 2009
Ranbaxy Laboratories Ltd
Strategic Direction
Key Facts
  Summary 24 Ranbaxy Laboratories Ltd: Key Facts
  Summary 25 Ranbaxy Laboratories Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 26 Ranbaxy Laboratories Ltd: Competitive Position 2009
Trends
Category Data
  Table 16 Sales of Wound Treatments by Subsector: Value 2004-2009
  Table 17 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
  Table 18 Wound Treatments Company Shares by Value 2005-2009
  Table 19 Wound Treatments Brand Shares by Value 2006-2009
  Table 20 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
  Table 21 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
Skip to top


Wound Treatments - Guatemala US$ 990.00 May, 2010 · 20 pages
Wound Treatments - Indonesia US$ 990.00 Mar, 2010 · 41 pages
Wound Treatments - Iran US$ 990.00 May, 2010 · 22 pages
Wound Treatments - Israel US$ 990.00 Jun, 2010 · 36 pages
Wound Treatments - Japan US$ 990.00 Jun, 2010 · 46 pages

Ask Your Question

Wound Treatments - India
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: